|
Re: debenture
|
|
Resverlogix Corp.
|
Mar 21, 2023 09:57AM
|
|
Re: December 22, 2020.wideout
|
2
|
Resverlogix Corp.
|
Oct 10, 2020 02:22PM
|
|
Re: Quote from a January 19, 2021 review
|
2
|
Resverlogix Corp.
|
Jan 21, 2021 08:45PM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
3
|
Resverlogix Corp.
|
Mar 18, 2022 11:31AM
|
|
Re: Shake it Up!
|
3
|
Resverlogix Corp.
|
Dec 24, 2020 12:50AM
|
|
Re: did don say ...?
|
3
|
Resverlogix Corp.
|
Aug 11, 2022 11:55PM
|
|
Re: COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
|
3
|
Resverlogix Corp.
|
Dec 14, 2021 02:50PM
|
|
Where are the Questions ?
|
3
|
Resverlogix Corp.
|
Jun 21, 2022 04:42PM
|
|
Re: Head above water ....
|
3
|
Resverlogix Corp.
|
Sep 22, 2020 12:27PM
|
|
Re: Leading From Behind
|
3
|
Resverlogix Corp.
|
Oct 13, 2020 05:11PM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
3
|
Resverlogix Corp.
|
Jun 22, 2022 01:43PM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
3
|
Resverlogix Corp.
|
Dec 22, 2020 02:00PM
|
|
Re: U.S. to Invest $3 Billion on Developing Pills to Treat Covid
|
3
|
Resverlogix Corp.
|
Jun 17, 2021 05:00PM
|
|
Re: Sneaking Suspicion...
|
4
|
Resverlogix Corp.
|
Feb 04, 2021 10:51PM
|
|
Re: December 22, 2020.
|
4
|
Resverlogix Corp.
|
Oct 10, 2020 11:49AM
|
|
Re: RVX Current Status
|
4
|
Resverlogix Corp.
|
Feb 27, 2020 12:00PM
|
|
Re: The latest numbers for Alberta.
|
4
|
Resverlogix Corp.
|
Sep 16, 2021 09:32PM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
4
|
Resverlogix Corp.
|
Jun 22, 2022 11:24AM
|
|
Re: PNAS
|
4
|
Resverlogix Corp.
|
Jan 02, 2021 11:01AM
|
|
Re: Did DM show some cards?
|
4
|
Resverlogix Corp.
|
Sep 07, 2020 12:53PM
|
